Atlas Trials

A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects

Clinical trial NCT06541457 · COMPLETED

Trial details

NCT number
NCT06541457
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2024-08-15
Primary completion
2025-07-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.